CME
Get Free CME Credits and Real Time Test Results.

Visit www.CMEToday.net. All live CME activities from Diabetic Microvascular
Complications Today are featured on this site.

November.December 2006
Control of Systemic Factors Can Preserve Vision
in Diabetic Retinopathy

Jointly sponsored by The Dulaney Foundation and
Diabetic Microvascular Complications Today.
Release Date: January 1, 2007. Expiration January 31, 2008.
This continuing medical education activity is supported by an
educational grant from Eli Lilly and Company.

By Michael Colucciello, MD

September/October 2006
New and Standard Treatment Options
for Patients With Type 2 Diabetes

Jointly sponsored by The Dulaney Foundation and
Diabetic Microvascular Complications Today.
Release Date: October 2006. Expiration Date: October 31, 2007.
This continuing medical education activity is supported by
an educational grant from Eli Lilly and Company.

By Nathan A. Painter, PharmD

July/August 2006
Understanding the Relationship Between
Hyperglycemia and Microvascular Complications

Jointly sponsored by The Dulaney Foundation and
Diabetic Microvascular Complications Today.
Release Date: August 2006. Expiration Date: August 31, 2007.
This continuing medical education activity is supported by
an educational grant from Eli Lilly and Company.

By Bernard Zinman, MD

May/June 2006
Treating Diabetes by Modifying GLP-1 Activity:
Current Options and New Developments

Jointly sponsored by The Dulaney Foundation and
Diabetic Microvascular Complications Today.
Release Date: June 2006. Expiration Date: June 30, 2007.
This continuing medical education activity is supported by
an educational grant from Eli Lilly and Company.

By Kathleen Dungan, MD

March /April 2006
Detection of Peripheral Neuropathy: Screening and Diagnosis Strategies

Jointly sponsored by The Dulaney Foundation and
Diabetic Microvascular Complications Today.
Release Date: March 2006. Expiration Date: March 31, 2007.
This continuing medical education activity is supported by
an educational grant from Eli Lilly and Company.

By David G. Armstrong, DPM, PhD

January /Febraury 2006
Opportunities for Therapeutic Intervention:
Molecular Biology of Diabetic Retinopathy

Jointly sponsored by The Dulaney Foundation and
Diabetic Microvascular Complications Today.
Release Date: January 2006. Expiration Date: January 31, 2007.
This continuing medical education activity is supported by
an educational grant from Eli Lilly and Company.

By Lloyd Paul Aiello, MD, PHD

November /December 2005
Increasing Physical Activity Without Increasing Pain in Diabetic Patients

Jointly sponsored by The Dulaney Foundation and Diabetic Microvascular Complications Today. Release Date: November 2005. Expiration November 30, 2006. This continuing medical education activity is supported by an educational grant from Eli Lilly and Company.

By Karen Kemmis, PT, DPT, MS, CDE

September /October 2005
Update on Complementary Therapies in Diabetes

Jointly sponsored by The Dulaney Foundation and Diabetic Microvascular Complications Today. Release Date: September 2005. Expiration September 30, 2006.This continuing medical education activity is supported by an educational grant from Eli Lilly and Company.

This activity is taken from a presentation by Laura Shane-Mcwhorter, PharmD, American Association of Diabetes Educators 32nd meeting and Exhibition August 10-13, 2005, Washington, DC

July /August 2005
Control of Systemic Factors Can Preserve Vision in Diabetic Retinopathy

Jointly sponsored by The Dulaney Foundation and Diabetic Microvascular Complications Today.

Release Date: July 2005. Expiration July 31, 2006.
This continuing medical education activity is supported by an
educational grant from Eli Lilly and Company.

By Michael Colucciello, MD

May /June 2005
Postprandial Glucose is Important in Attaining Total Glycemic Control
Jointly sponsored by The Dulaney Foundation and Diabetic Microvascular Complications Today.

Release Date: May 2005. Expiration May 31, 2006.
This continuing medical education activity is supported by an unrestricted
educational grant from Eli Lilly and Company.

By Steven V. Edelman, MD

March/April 2005
Current Treatments Fobr Obesity
Jointly sponsored by The Dulaney Foundation and Diabetic Microvascular Complications Today.

Release Date: March 2005. Expiration Date: March 31, 2006. This continuing medical education activity is supported by an unrestricted educational grant from Eli Lilly and Company.

By Carol Motycka, PharmD; and Erin St. Onge, PharmD

January/February 2005
The Epidemic of Obesity and Diabetes: Special Needs, Risks for Women

Summary based on presentations made by Frances Ashe-Goins, RN;Judith Fradkin, MD, DDEMD/NIDDK; and Michelle D. Owens, PhD

November/December 2004
Diabetic Nephropathy
By Mohamed Atta, MD

October 2004
The Metabolic Syndrome
By Serge A. Jabbour, MD; and Jeffery L. Miller, MD